The Wingman Extendable Tip Support Catheter is intended to be used in conjunction with steerable guidewires to access discreet regions of the peripheral vasculature. It may be used to facilitate placement and exchange of guidewires and other interventional devices and provide a conduit for the delivery of saline solutions or diagnostic/therapeutic agents.
Device Story
The Wingman Extendable Tip Support Catheter is a peripheral vascular support catheter featuring a concealed radiopaque beveled guide-tip and an activating handle. It is used by clinicians to provide additional support to steerable guidewires during navigation of peripheral vasculature. The device acts as a conduit for guidewire exchange and the delivery of diagnostic or therapeutic agents. The clinician operates the device manually, using the handle to extend the tip to assist in accessing challenging vascular anatomy. By providing enhanced support, the device facilitates the placement of interventional tools, potentially improving procedural success in peripheral vascular interventions.
Clinical Evidence
Bench testing only. Performance was verified through simulated use, tensile strength, torque, pressure testing, coating/plating verification, corrosion testing, and dimensional/visual inspections. No clinical data was required or provided.
Technological Characteristics
Support catheter with concealed radiopaque beveled guide-tip and activating handle. Features include variable lengths (65cm, 150cm) and modified strain-relief. Functions as a conduit for guidewires and fluid delivery. Mechanical device; no software or energy source.
Indications for Use
Indicated for patients requiring access to discrete regions of the peripheral vasculature to facilitate placement and exchange of guidewires and interventional devices, or for delivery of saline/diagnostic/therapeutic agents.
Regulatory Classification
Identification
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
K193596 — Wingman 14, Wingman 14C, Wingman 18, Wingman 35 · Reflow Medical · Feb 20, 2020
K170996 — Wingman 14C Crossing Catheter · Reflow Medical, Inc. · Jun 9, 2017
Submission Summary (Full Text)
{0}------------------------------------------------
2013
#### Section 6
### 6. 510(k) Summary
This 510(k) summary information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
| APPLICANT: | ReFlow Medical |
|------------------------|----------------------------------------------------------------------------------------------------------|
| DATE PREPARED: | August 1, 2013 |
| CONTACT PERSON: | Rebecca K Pine<br>ReFlow Medical<br>1003 Calle Sombra<br>San Clemente, CA 92673<br>Phone: (760) 809.5178 |
| TRADE NAME: | Wingman Extendable Tip Support Catheter |
| COMMON NAME: | Guide Catheter |
| CLASSIFICATION NAME: | Percutaneous Catheter |
| DEVICE CLASSIFICATION: | Class 2, per 21 CFR 870.1250 |
| PRODUCT CODE | DQY |
| | PREDICATE DEVICES: Wingman Extendable Support Catheter (K120178) |
# Substantially Equivalent To:
The modified Wingman Extendable Tip Support Catheter is substantially equivalent in intended use, principal of operation and technological characteristics to the Wingman Extendable Support Catheter cleared under premarket notification K120178.
#### Description of the Device Subject to Premarket Notification:
The Wingman Extendable Tip Support Catheter is a device intended to provide additional support to a steerable guidewire when accessing discrete regions of the peripheral vasculature. The device consists of a support catheter, with a concealed radiopaque beveled guide-tip, and activating handle. The through-lumen of the device can serve as a conduit for the delivery of diagnostic and therapeutic agents.
#### Indication for Use:
The Wingman Extendable Tip Support Catheter is intended to be used in conjunction with steerable guidewires to access discreet regions of the peripheral vasculature. It may be used to facilitate placement and exchange of guidewires and other interventional devices and provide a conduit for the delivery of saline solutions or diagnostic/therapeutic agents.
ReFlow Medical Modified Wingman Extendable Tip Support Catheter
Page 20 of 61 Premarket Notification
{1}------------------------------------------------
# Technical Characteristics:
The modified Wingman Extendable Tip Support Catheter has similar physical and technical characteristics to the predicate device. The modified Wingman and predicate Wingman devices differ in the following:
- Product line extension; new lengths: 65cm, 150cm .
- Modified strain-relief .
# Performance Data:
All necessary testing has been performed for the Wingman Extendable Tip Support Catheter to assure substantial equivalence to the predicate device and demonstrate the device performs as intended. All testing was performed on test units representative of finished devices.
The device design was qualified through the following tests:
- Simulated Use .
- Tensile Strength .
- Torque ●
- . Pressure Test
- Coating/Plating verification o
- Corrosion Test .
- Dimensional verification and visual inspections .
The modified Wingman Extendable Tip Support Catheter met all specified criteria and did not raise new safety or performance questions.
# Basis for Determination of Substantial Equivalence:
The Indication/Intended Use and the fundamental scientific technology of the modified device have not been changed and are the same as those described in the unmodified predicate device. The modified Wingman Extendable Tip Support Catheter is determined by ReFlow Medical, to be substantially equivalent to the Wingman Extendable Tip Support Catheter (K120178).
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird with three stylized wing shapes.
#### DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
September 19, 2013
Food and Drig Administration 10903 New Hampshire Avenue Document Contral Center - WO60-G609 Silver Spring, MD 20993-0002
Reflow Medical, Inc. c/o Ms. Rebecca K. Pine Head of Regulatory Affairs/Quality Assurance 1003 Calle Sombra San Clemente, CA 92673
Re: K132420
Trade/Device Name: Wingman Extendable Tip Support Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutancous Catheter Regulatory Class: Class II Product Code: DQY Dated: August 1, 2013 Received: August 5, 2013
Dear Ms. Pine:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
{3}------------------------------------------------
Page 2 - Ms. Rebecca K. Pine
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
# Bram D. Zuckerman -S
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
5. Indications for Use Statement
#### INDICATIONS FOR USE STATEMENT
510(k) Number (if known):
Device Name: Wingman Extendable Tip Support Catheter
Indications for Use:
The Wingman Extendable Tip Support Catheter is intended to be used in conjunction with steerable guidewires to access discreet regions of the peripheral vasculature. It may be used to facilitate placement and exchange of guidewires and other interventional devices and provide a conduit for the delivery of saline solutions or diagnostic/therapeutic agents.
AND/OR
Prescription Use X (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)
Page _________________________________________________________________________________________________________________________________________________________________________
# (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
# Bram D. Zuckerman -S 2013.09.19 13:39:59 -04'00'
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.